<div id="readability-page-1"><div><p>As the European markets navigate through uncertainty driven by geopolitical tensions and fluctuating energy prices, the pan-European STOXX Europe 600 Index has shown modest gains, reflecting cautious optimism among investors. In this environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholder interests, potentially offering resilience amid market volatility.</p><h3>Top 10 Growth Companies With High Insider Ownership In Europe</h3><div><table><tbody><tr><td><strong>Name</strong></td><td><strong>Insider Ownership</strong></td><td><strong>Earnings Growth</strong></td></tr><tr><td>MilDef Group (OM:MILDEF)</td><td>13.7%</td><td>34.7%</td></tr><tr><td>MedinCell (ENXTPA:MEDCL)</td><td>11.5%</td><td>117.6%</td></tr><tr><td>KebNi (OM:KEBNI B)</td><td>35%</td><td>80.1%</td></tr><tr><td>Induct (OB:INDCT)</td><td>10.5%</td><td>98.6%</td></tr><tr><td>Elliptic Laboratories (OB:ELABS)</td><td>21.6%</td><td>124.9%</td></tr><tr><td>CTT Systems (OM:CTT)</td><td>17.4%</td><td>42.7%</td></tr><tr><td>Clavister Holding AB (publ.) (OM:CLAV)</td><td>18%</td><td>116.2%</td></tr><tr><td>Circus (XTRA:CA1)</td><td>21.9%</td><td>88.1%</td></tr><tr><td>Bonesupport Holding (OM:BONEX)</td><td>10.2%</td><td>34%</td></tr><tr><td>Bergen Carbon Solutions (OB:BCS)</td><td>10.2%</td><td>55.5%</td></tr></tbody></table></div><p>Click here to see the full list of 221 stocks from our Fast Growing European Companies With High Insider Ownership screener.</p><p>Let's dive into some prime choices out of the screener.</p><h2>P/F Bakkafrost (OB:BAKKA)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> P/F Bakkafrost, along with its subsidiaries, is involved in the production and sale of salmon products across North America, Western Europe, Eastern Europe, Asia, and other international markets; it has a market cap of NOK26.85 billion.</p><p><strong>Operations:</strong> The company's revenue segments include Sales and Other at DKK10.28 billion, Farming Faroe Islands at DKK4.05 billion, Fishmeal, Oil and Feed at DKK2.60 billion, Services at DKK920.52 million, Farming Scotland at DKK1.12 billion, Freshwater Faroe Islands at DKK896.77 million, and Freshwater Scotland at DKK169.46 million.</p><p><strong>Insider Ownership:</strong> 23.7%</p><p><strong>Earnings Growth Forecast:</strong> 36% p.a.</p><p>P/F Bakkafrost, a European growth company with significant insider ownership, is forecast to achieve substantial earnings growth of 36% annually, outpacing the Norwegian market. Despite trading at a considerable discount to its estimated fair value, the company's revenue growth is projected at 12.6% per year. Recent amendments in its Articles of Association allow share buybacks up to 10% of total capital. However, recent earnings showed a decline in annual net income despite quarterly improvements.</p><ul><li>Click here to discover the nuances of P/F Bakkafrost with our detailed analytical future growth report.</li><li>Insights from our recent valuation report point to the potential undervaluation of P/F Bakkafrost shares in the market.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/46d88a0e-736c-49a8-b85c-575da11fb6fe/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/46d88a0e-736c-49a8-b85c-575da11fb6fe/chart/earnings-and-revenue-growth"/><figcaption>OB:BAKKA Earnings and Revenue Growth as at Apr 2026</figcaption></figure><h2>Sdiptech (OM:SDIP B)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Sdiptech AB (publ) offers technical services for infrastructures across several countries including Sweden, the United Kingdom, and the United States, with a market cap of SEK7.63 billion.</p><p><strong>Operations:</strong> The company's revenue segments include Safety &amp; Security (SEK430 million), Water &amp; Bioeconomy (SEK913 million), Energy &amp; Electrification (SEK1.07 billion), and Supply Chain &amp; Transportation (SEK2.08 billion).</p><p><strong>Insider Ownership:</strong> 11.6%</p><p><strong>Earnings Growth Forecast:</strong> 51.6% p.a.</p><p>Sdiptech, with strong insider ownership, is expected to grow earnings by 51.59% annually and become profitable within three years, surpassing average market growth. Although trading 54.2% below estimated fair value and analysts anticipate a 35.1% price increase, the company faces high debt levels. Recent activities include redeeming preference shares for SEK 184 million and repurchasing bonds worth SEK 250 million at a premium, indicating strategic financial restructuring efforts amidst its growth trajectory.</p><ul><li>Delve into the full analysis future growth report here for a deeper understanding of Sdiptech.</li><li>Our valuation report unveils the possibility Sdiptech's shares may be trading at a discount.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/087f171a-1bc7-42f1-8527-d29f5f936469/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/087f171a-1bc7-42f1-8527-d29f5f936469/chart/earnings-and-revenue-growth"/><figcaption>OM:SDIP B Earnings and Revenue Growth as at Apr 2026</figcaption></figure><h2>Redcare Pharmacy (XTRA:RDC)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Redcare Pharmacy NV operates an online pharmacy business across several European countries including the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €748.95 million.</p><p><strong>Operations:</strong> The company's revenue is segmented into €2.40 billion from the DACH region and €540 million internationally.</p><p><strong>Insider Ownership:</strong> 13.7%</p><p><strong>Earnings Growth Forecast:</strong> 53.5% p.a.</p><p>Redcare Pharmacy, with significant insider ownership, is forecast to achieve profitability within three years and surpass average market growth. Despite trading at 79.8% below its estimated fair value, it faces challenges like high share price volatility and a net loss of €37.7 million in 2025. Revenue is expected to grow between 13-15% in 2026, driven by digital healthcare innovations such as the PoPP module for e-prescriptions in Germany's telematics infrastructure modernization.</p><ul><li>Dive into the specifics of Redcare Pharmacy here with our thorough growth forecast report.</li><li>According our valuation report, there's an indication that Redcare Pharmacy's share price might be on the cheaper side.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bd9541e9-75b0-454c-8046-a7084a97c9e9/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bd9541e9-75b0-454c-8046-a7084a97c9e9/chart/ownership-breakdown"/><figcaption>XTRA:RDC Ownership Breakdown as at Apr 2026</figcaption></figure><h2>Taking Advantage</h2><ul><li>Click this link to deep-dive into the 221 companies within our Fast Growing European Companies With High Insider Ownership screener.</li><li>Ready For A Different Approach? Find companies with promising cash flow potential yet trading below their fair value.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders.      It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities.      All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p><div><h3><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>• Connect an unlimited number of Portfolios and see your total in one currency<br/>• Be alerted to new Warning Signs or Risks via email or mobile<br/>• Track the Fair Value of your stocks<br/></p><p>Try a Demo Portfolio for Free</p></div></div></div>

BAKK

<p>The article discusses three European growth companies with high insider ownership: P/F Bakkafrost, Sdiptech, and Redcare Pharmacy. P/F Bakkafrost, with 23.7% insider ownership, is expected to grow earnings by 36% annually despite recent declines in net income. Sdiptech, with 11.6% insider ownership, forecasts a 51.6% annual earnings growth but faces high debt levels. Redcare Pharmacy, holding 13.7% insider ownership, anticipates 53.5% earnings growth while trading significantly below its estimated fair value. The article highlights the potential resilience of these companies amid market volatility.</p>

3 European Growth Companies With High Insider Ownership